Can we reach suitable 161Tb purity for medical applications using the 160Gd(d,n) reaction?

Nigron, Etienne; Guertin, Arnaud; Haddad, Férid; Granger, Lucas; Rayer, Maxence; Rintaud, Alexandre

doi:10.1016/j.apradiso.2023.110927

Applied Radiation and Isotopes

2023

DOI: 10.1016/j.apradiso.2023.110927

|View full text |Cite

Can we reach suitable 161Tb purity for medical applications using the 160Gd(d,n) reaction?

Etienne Nigron,

Arnaud Guertin,

Férid Haddad

et al.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

Supporting

Mentioning

Contrasting

Year Published

2024

Publication Types

Select...

Article1

Relationship

Self Cite0

Independent1

Authors

Journals

Cited by 1 publication

References 15 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

Estimation of cyclotron–based ¹⁶¹Tb production yields via ¹⁶⁰Gd(d, n)¹⁶¹Tb nuclear reaction

Glumac,

Cherepennikov

2024

J. Phys.: Conf. Ser.

View full text Add to dashboard Cite

Theoretical yield of cyclotron-based production route for 161Tb isotope using enriched oxide target, relying on the nuclear reaction 160Gd (d, n)161Tb, is calculated. The yield of 161Tb and radioactive impurities (160Tb and 161Gd) is calculated for range of initial deuteron energies up to 30 MeV, as well as suitable target thickness for each of the energies. Initial particle energy of 20 MeV can be considered preferable in such production line, since further increase of energy (over 10-12 MeV) leads to cross section decrease for the targeted isotope and the yield curve slightly flattens, and is yet achievable for existing cyclotrons. It is concluded that evaluated production route cannot produce carrier-free 161Tb under considered conditions. To obtain results on stopping power and particle range SRIM software was used.

show abstract

Estimation of cyclotron–based ¹⁶¹Tb production yields via ¹⁶⁰Gd(d, n)¹⁶¹Tb nuclear reaction

Glumac,

Cherepennikov

2024

J. Phys.: Conf. Ser.

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Can we reach suitable 161Tb purity for medical applications using the 160Gd(d,n) reaction?

Cited by 1 publication

References 15 publications

Estimation of cyclotron–based ¹⁶¹Tb production yields via ¹⁶⁰Gd(d, n)¹⁶¹Tb nuclear reaction

Estimation of cyclotron–based ¹⁶¹Tb production yields via ¹⁶⁰Gd(d, n)¹⁶¹Tb nuclear reaction

Contact Info

Product

Resources

About

Can we reach suitable 161Tb purity for medical applications using the 160Gd(d,n) reaction?

Cited by 1 publication

References 15 publications

Estimation of cyclotron–based 161Tb production yields via 160Gd(d, n)161Tb nuclear reaction

Estimation of cyclotron–based 161Tb production yields via 160Gd(d, n)161Tb nuclear reaction

Contact Info

Product

Resources

About

Estimation of cyclotron–based ¹⁶¹Tb production yields via ¹⁶⁰Gd(d, n)¹⁶¹Tb nuclear reaction

Estimation of cyclotron–based ¹⁶¹Tb production yields via ¹⁶⁰Gd(d, n)¹⁶¹Tb nuclear reaction